A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma.

Author: DahlR, JohanssonS A

Paper Details 
Original Abstract of the Article :
Budesonide by inhalation and placebo were tested in 18 patients with moderate chronic bronchial asthma. Three dose levels of budesonide were used (25, 100 and 400 micrograms q.i.d.) and the patients were to take two puffs q.i.d. in all periods. The active treatment was investigated using double-blin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1398-9995.1988.tb00415.x

データ提供:米国国立医学図書館(NLM)

A Dose-Dependent Effect of Budesonide on Bronchial Asthma

In the realm of respiratory medicine, a key challenge lies in managing bronchial asthma, a condition characterized by inflammation and narrowing of the airways. This study investigates the efficacy of budesonide, a corticosteroid medication, in alleviating asthma symptoms. The researchers employed a double-blind crossover design, a technique that ensures both patients and researchers are unaware of the treatment received, to examine the effects of three different doses of budesonide compared to a placebo. They discovered that budesonide significantly improved lung function, as measured by peak expiratory flow (PEF) values, in a dose-dependent manner. While this study provides valuable insights into the effectiveness of budesonide, it also highlights the importance of patient compliance. The researchers observed that patients tended to overuse the medication at the lowest dose, suggesting the need for careful monitoring and patient education. This study sheds light on the potential of budesonide as a therapeutic option for bronchial asthma, emphasizing the importance of individualizing treatment strategies.

Budesonide's Impact on Asthma Management

This study reveals that budesonide effectively reduces the severity of bronchial asthma. The dose-dependent response suggests that a higher dose may be necessary for some patients, but careful monitoring is crucial to prevent over-reliance on medication. This research contributes to a better understanding of personalized medicine and the need for individualised treatment strategies.

Asthma Management: A Balancing Act

As a camel trekking across the vast expanse of the desert, I've learned that balance is key to survival. Just like maintaining a healthy equilibrium in the desert, managing asthma requires a delicate balance between medication and lifestyle adjustments. This study reminds us that while medications like budesonide can be effective, they are just one piece of the puzzle. Lifestyle factors, such as avoiding triggers and managing stress, play a crucial role in controlling asthma symptoms.

Dr. Camel's Conclusion

Budesonide's effectiveness in treating bronchial asthma and the importance of patient compliance are key takeaways from this study. It's a reminder that while medications can be powerful tools in managing chronic diseases, a holistic approach encompassing lifestyle adjustments is essential for optimal health outcomes.
Date :
  1. Date Completed 1988-07-14
  2. Date Revised 2019-08-20
Further Info :

Pubmed ID

3287996

DOI: Digital Object Identifier

10.1111/j.1398-9995.1988.tb00415.x

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.